针对三阴性乳腺癌的量身定制疗法:当前的情况和未来的看法
Yumna Khan1, Sana Rizvi2, Ali Raza3
1Institute of Biotechnology and Genetic Engineering, The University of Agriculture, Peshawar, 25130, Pakistan. yumnakhan4514@gmail.com.
Naunyn-Schmiedeberg's archives of pharmacology
|March 3, 2025
概括
三重阴性乳腺癌 (TNBC) 治疗由于其变异性而具有挑战性. 本综述探讨了创新的疗法和分子标,包括免疫检查点抑制剂和TNBC的个性化医疗方法.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 三重阴性乳腺癌 (TNBC) 由于其异质性和攻击性而带来了重大治疗挑战.
- 对TNBC存在有限的向治疗选择,需要新的策略.
研究的目的:
- 审查三阴性乳腺癌的创新治疗策略.
- 突出最近的发展和TNBC治疗的未来方向.
主要方法:
- 对分子分析 (转录组,基因组) 的全面审查,以确定关键的TNBC目标.
- 对针对特定途径 (例如,免疫检查点,DNA损伤反应,PI3K/AKT/mTOR) 的新型治疗剂的分析.
- 探索组合疗法,表观遗传调节器和新兴技术.
主要成果:
- 在TNBC中的关键分子标包括BRCA1/2,PIK3CA,雄激素受体 (AR),EGFR和免疫检查点.
- 新兴疗法包括免疫检查点抑制剂 (ICI),AR抑制剂,PARP抑制剂和PI3K/AKT/mTOR途径抑制剂.
- 组合疗法,DNA损伤反应向和表观遗传调节器显示出有希望的结果.
结论:
- 个性化医学,人工智能 (AI),预测生物标志物和机器学习 (ML) 对于推进TNBC治疗计划至关重要.
- 未来的方向侧重于量身定制的治疗方法,利用分子洞察力和先进技术.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461


